Ascendis Pharma A/S (ASND)
242.95
+1.24
(+0.51%)
USD |
NASDAQ |
Apr 16, 16:00
242.99
+0.04
(+0.02%)
After-Hours: 20:00
Ascendis Pharma Free Cash Flow : 51.45M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Novo Nordisk A/S | 4.403B |
| Evaxion AS | -- |
| DBV Technologies SA | -122.10M |
| Biodexa Pharmaceuticals Plc | -8.310M |
| Trinity Biotech Plc | -9.605M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 83.03M |
| Cash from Investing (Quarterly) | -3.872M |
| Cash from Financing (Quarterly) | 9.818M |
| Free Cash Flow Per Share (Quarterly) | 1.290 |
| Free Cash Flow to Equity (Quarterly) | 11.33M |
| Free Cash Flow to Firm (Quarterly) | 168.95M |
| Free Cash Flow Yield | 0.35% |